Hainan Simcere Pharmaceutical Co., Ltd.
As of 18 November 2026, for the company name Hainan Simcere Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 19 active records with this name as holder; 18 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
33 acceptance records as first applicant, grouped into 20 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
阿莫西林克拉维酸钾颗粒 · No verified English name 1 records · Latest accepted 2026/07/27
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601434 | Supplement | 2026/07/27 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
Bedaquiline Fumarate Tablets 2 records · Latest accepted 2026/07/08
Supplement · 1Generic · 1
阿莫西林克拉维酸钾干混悬剂 · No verified English name 2 records · Latest accepted 2026/04/03
Supplement · 2
Diclofenac Sodium Dual Release Enteric-coated Capsules 1 records · Latest accepted 2025/09/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503505 | Generic | 2025/09/24 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
盐酸达利雷生片 · No verified English name 2 records · Latest accepted 2025/08/25
Generic · 2
Sevelamer Carbonate Tablets 1 records · Latest accepted 2025/05/20
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501033 | Supplement | 2025/05/20 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
泊沙康唑注射液 · No verified English name 3 records · Latest accepted 2025/05/01
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500896 | Supplement | 2025/05/01 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2401473 | Supplement | 2024/09/14 | Hainan Simcere Pharmaceutical Co., Ltd.; Hangzhou Ao Ya Bio Technology Co., Ltd. romanized | CDE ↗ |
| CYHB2400253 | Supplement | 2024/02/08 | Hainan Simcere Pharmaceutical Co., Ltd.; Hangzhou Ao Ya Bio Technology Co., Ltd. romanized | CDE ↗ |
环硅酸锆钠散 · No verified English name 2 records · Latest accepted 2025/01/23
Generic · 2
注射用盐酸曲拉西利 · No verified English name 3 records · Latest accepted 2024/09/14
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401474 | Supplement | 2024/09/14 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2400165 | Supplement | 2024/01/27 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2300123 | Supplement | 2023/01/14 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
Montmorillonite Powder 1 records · Latest accepted 2024/09/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401397 | Supplement | 2024/09/10 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
Ibuprofen Arginine Tablets 1 records · Latest accepted 2024/06/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401809 | Generic | 2024/06/17 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
Amoxicillin Capsules 1 records · Latest accepted 2023/07/17
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301624 | Supplement | 2023/07/17 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
苯磺酸左氨氯地平片 · No verified English name 1 records · Latest accepted 2023/02/02
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350123 | Supplement | 2023/02/02 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
Ritonavir Tablets 1 records · Latest accepted 2023/01/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300046 | Generic | 2023/01/06 | Hainan Simcere Pharmaceutical Co., Ltd.; Guangzhou Bo Si Tao Kong Shi Pharma Co., Ltd. romanized | CDE ↗ |
注射用SIM1910-09 · No verified English name 2 records · Latest accepted 2022/08/17
Supplement · 1New drug · 1
氢溴酸右美沙芬颗粒 · No verified English name 1 records · Latest accepted 2022/03/30
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2200560 | Supplement | 2022/03/30 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
阿普米司特片 · No verified English name 3 records · Latest accepted 2021/12/09
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2102167 | Generic | 2021/12/09 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2102166 | Generic | 2021/12/09 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2102165 | Generic | 2021/12/09 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
Edoxaban Tosilate Tablets 3 records · Latest accepted 2021/06/02
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101235 | Generic | 2021/06/02 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2101234 | Generic | 2021/06/02 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2101233 | Generic | 2021/06/02 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
Batroxobin Injection 1 records · Latest accepted 2021/05/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2101007 | Generic | 2021/05/11 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
Voriconazole for Injection 1 records · Latest accepted 2021/01/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2100002 | Generic | 2021/01/11 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
Changes in the last 90 days
1 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Supplement delivery: 1 application
- 2026/10/20Supplement delivery
Bedaquiline Fumarate Tablets
CYHB2601292
Fact date: 2026/10/20 · Publication date: 2026/10/21 · Date added to this site: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 7 ↗
Under review
2 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 阿莫西林克拉维酸钾颗粒 · No verified English name | CYHB2601434 | Supplement | 2026/07/27 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
| Diclofenac Sodium Dual Release Enteric-coated Capsules | CYHS2503505 | Generic | 2025/09/24 | Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
Catalogue holder records
19 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 盐酸达利雷生片 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Hainan Simcere Pharmaceutical Co., Ltd. | 国药准字H20265312 | 2026/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 盐酸达利雷生片 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Hainan Simcere Pharmaceutical Co., Ltd. | 国药准字H20265313 | 2026/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 环硅酸锆钠散 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Hainan Simcere Pharmaceutical Co., Ltd. | 国药准字H20264562 | 2026/05/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 环硅酸锆钠散 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Hainan Simcere Pharmaceutical Co., Ltd. | 国药准字H20264561 | 2026/05/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ibuprofen Arginine Tablets | Hainan Simcere Pharmaceutical Co., Ltd. | Hainan Simcere Pharmaceutical Co., Ltd. | 国药准字H20256066 | 2025/11/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ritonavir Tablets | Hainan Simcere Pharmaceutical Co., Ltd. | Guangzhou Bo Si Tao Kong Shi Pharma Co., Ltd. romanized | 国药准字H20244017 | 2024/06/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 苯磺酸左氨氯地平片 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Hainan Simcere Pharmaceutical Co., Ltd. | 国药准字H20093088 | 2024/01/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 阿普米司特片 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Hainan Simcere Pharmaceutical Co., Ltd. | 国药准字H20234658 | 2023/12/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 阿普米司特片 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Hainan Simcere Pharmaceutical Co., Ltd. | 国药准字H20234657 | 2023/12/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 阿普米司特片 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Hainan Simcere Pharmaceutical Co., Ltd. | 国药准字H20234656 | 2023/12/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sevelamer Carbonate Tablets | Hainan Simcere Pharmaceutical Co., Ltd. | Hainan Simcere Pharmaceutical Co., Ltd. | 国药准字H20233347 | 2023/03/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bedaquiline Fumarate Tablets | Hainan Simcere Pharmaceutical Co., Ltd. | Hainan Simcere Pharmaceutical Co., Ltd. | 国药准字H20233201 | 2023/02/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Edoxaban Tosilate Tablets | Hainan Simcere Pharmaceutical Co., Ltd. | Hainan Simcere Pharmaceutical Co., Ltd. | 国药准字H20223669 | 2022/09/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Edoxaban Tosilate Tablets | Hainan Simcere Pharmaceutical Co., Ltd. | Hainan Simcere Pharmaceutical Co., Ltd. | 国药准字H20223668 | 2022/09/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Edoxaban Tosilate Tablets | Hainan Simcere Pharmaceutical Co., Ltd. | Hainan Simcere Pharmaceutical Co., Ltd. | 国药准字H20223670 | 2022/09/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 阿莫西林克拉维酸钾干混悬剂 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Hainan Simcere Pharmaceutical Co., Ltd. | 国药准字H20010580 | 2022/05/13 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Mycophenolate Mofetil Capsules | Hainan Simcere Pharmaceutical Co., Ltd. | Hainan Simcere Pharmaceutical Co., Ltd. | 国药准字H20213150 | — | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Amoxicillin and Clavulanate Potassium Tablets | Hainan Simcere Pharmaceutical Co., Ltd. | Hainan Simcere Pharmaceutical Co., Ltd. | 国药准字H20213933 | 2021/12/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nifedipine Controlled-release Tablets | Hainan Simcere Pharmaceutical Co., Ltd. | Hainan Simcere Pharmaceutical Co., Ltd. | 国药准字H20213314 | 2021/04/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
18 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 盐酸曲拉西利 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Y20220000646 | A | 2026/03/04 | CDE ↗ |
| 蒙脱石 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Y20190009512 | A | 2025/02/28 | CDE ↗ |
| 盐酸伐昔洛韦 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Y20190008123 | A | 2024/06/28 | CDE ↗ |
| 依达拉奉 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Y20190007845 | A | 2025/04/09 | CDE ↗ |
| 艾拉莫德 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Y20190006390 | A | 2026/03/18 | CDE ↗ |
| 盐酸昂丹司琼 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Y20190006208 | A | 2024/06/28 | CDE ↗ |
| 苯磺酸左氨氯地平 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Y20190006162 | A | 2024/06/26 | CDE ↗ |
| 炎琥宁 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Y20190006161 | A | 2024/07/05 | CDE ↗ |
| 帕米膦酸二钠 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Y20190006160 | A | 2024/06/26 | CDE ↗ |
| 琥珀酸舒马普坦 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Y20190003411 | A | 2024/06/26 | CDE ↗ |
| 马来酸氨氯地平 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Y20190002901 | A | 2025/03/20 | CDE ↗ |
| 尿囊素铝 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Y20190002900 | A | 2025/03/22 | CDE ↗ |
| 萘哌地尔 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Y20190002899 | A | 2024/06/26 | CDE ↗ |
| 盐酸贝那普利 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Y20190001947 | A | 2024/06/26 | CDE ↗ |
| 头孢特仑新戊酯 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Y20190001946 | A | 2024/06/26 | CDE ↗ |
| 美洛昔康 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Y20190001899 | A | 2024/06/26 | CDE ↗ |
| 蒙脱石 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Y20190000520 | A | 2025/05/20 | CDE ↗ |
| 蒙脱石 · No verified English name | Hainan Simcere Pharmaceutical Co., Ltd. | Y20180001015 | I | 2019/07/31 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
10 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 注射用盐酸曲拉西利 · No verified English name | CYHB2601825 | Supplement | 2026/09/29 | Xian Sheng Zai Ming Pharmaceuticals Co., Ltd. romanized; Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用盐酸曲拉西利 · No verified English name | CYHB2601824 | Supplement | 2026/09/29 | Xian Sheng Zai Ming Pharmaceuticals Co., Ltd. romanized; Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
| SIM0811注射液 · No verified English name | CXHL2501035 | New drug | 2025/09/26 | Jiangsu Xian Sheng Pharma Co., Ltd. romanized; Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
| 玛氘诺沙韦颗粒 · No verified English name | CXHS2500115 | New drug | 2025/09/03 | Jia Xing An Di Kang Bio Technology Co., Ltd. romanized; Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用盐酸曲拉西利 · No verified English name | CYHB2500158 | Supplement | 2025/01/21 | Hainan Xian Sheng Zai Ming Pharmaceuticals Co., Ltd. romanized; Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用盐酸曲拉西利 · No verified English name | CYHB2500157 | Supplement | 2025/01/21 | Hainan Xian Sheng Zai Ming Pharmaceuticals Co., Ltd. romanized; Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
| Edaravone and Dexborneol Concentrated Solution for Injection | CYHB2302268 | Supplement | 2023/10/13 | Simcere Pharmaceutical Co., Ltd.; Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
| Valsartan Film-Coated Tablets | CYHS2101139 | Generic | 2021/05/12 | Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized; Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
| Valsartan Film-Coated Tablets | CYHS2101138 | Generic | 2021/05/12 | Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized; Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
| Valsartan and Amlodipine Tablets(I) | CYHS2100211 | Generic | 2021/02/20 | Fujian Hai Xi Xin Yao Chuang Zhi Co., Ltd. romanized; Hainan Simcere Pharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.